ARCHIVES

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study

December 31, 2010

In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work

June 20, 1986

In Brief: Adamson Takes Job at Soft Drink Association; Zack Hall to Direct Neurological Institute

August 12, 1994

PCI Files Application For Research Base COP

September 9, 1994

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987